Splenic Marginal Zone Lymphoma

129 clinical trials · Condition

Record	Firm	Date
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia (NCT00005786)	National Cancer Institute (NCI)	2001-01-01
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies (NCT00014235)	Fred Hutchinson Cancer Center	2000-12-01
Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer (NCT00010192)	National Cancer Institute (NCI)	2000-12-01
506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma (NCT00005950)	National Cancer Institute (NCI)	2000-04-01
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00005799)	Fred Hutchinson Cancer Center	1999-11-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593)	Fred Hutchinson Cancer Center	1999-11-01
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241)	National Cancer Institute (NCI)	1999-10-01
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies (NCT01678443)	Fred Hutchinson Cancer Center	1999-09-01
Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00019708)	National Cancer Institute (NCI)	1999-06-01
Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00073918)	Fred Hutchinson Cancer Center	1999-02-01
Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma (NCT00003970)	National Cancer Institute (NCI)	1999-01-01
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma (NCT00003196)	Fred Hutchinson Cancer Center	1997-09-01
High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma (NCT01177371)	Case Comprehensive Cancer Center	1988-03-01

Track Splenic Marginal Zone Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.